These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21187103)

  • 1. The impact of vaccine side effects on the natural history of immunization programmes: an imitation-game approach.
    d'Onofrio A; Manfredi P; Poletti P
    J Theor Biol; 2011 Mar; 273(1):63-71. PubMed ID: 21187103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine demand driven by vaccine side effects: dynamic implications for SIR diseases.
    d'Onofrio A; Manfredi P
    J Theor Biol; 2010 May; 264(2):237-52. PubMed ID: 20149801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A game dynamic model for delayer strategies in vaccinating behaviour for pediatric infectious diseases.
    Bhattacharyya S; Bauch CT
    J Theor Biol; 2010 Dec; 267(3):276-82. PubMed ID: 20831873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
    Patel MM; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosenescence: Implications for vaccination programmes in adults.
    Lang PO; Govind S; Michel JP; Aspinall R; Mitchell WA
    Maturitas; 2011 Apr; 68(4):322-30. PubMed ID: 21316879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of pertussis in the world.
    Galazka A
    World Health Stat Q; 1992; 45(2-3):238-47. PubMed ID: 1462658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An emergency department-based vaccination program: overcoming the barriers for adults at high risk for vaccine-preventable diseases.
    Rimple D; Weiss SJ; Brett M; Ernst AA
    Acad Emerg Med; 2006 Sep; 13(9):922-30. PubMed ID: 16902048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the potential impact of Salmonella vaccines in an endemically infected dairy herd.
    Lu Z; Grohn YT; Smith RL; Wolfgang DR; Van Kessel JA; Schukken YH
    J Theor Biol; 2009 Aug; 259(4):770-84. PubMed ID: 19446567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a malaria vaccine for Papua New Guinea.
    Reeder JC
    P N G Med J; 2001; 44(1-2):17-23. PubMed ID: 12418674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccinating behaviour, information, and the dynamics of SIR vaccine preventable diseases.
    d'Onofrio A; Manfredi P; Salinelli E
    Theor Popul Biol; 2007 May; 71(3):301-17. PubMed ID: 17335862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The contribution of social medicine to vaccination in Austria].
    Kunze M
    Wien Med Wochenschr; 1998; 148(8-9):191-7. PubMed ID: 9677675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating herd immunity effects into cohort models of vaccine cost-effectiveness.
    Bauch CT; Anonychuk AM; Van Effelterre T; Pham BZ; Merid MF
    Med Decis Making; 2009; 29(5):557-69. PubMed ID: 19605882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
    Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
    Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postlicensure epidemiology of childhood vaccination: the Danish experience.
    Hviid A
    Expert Rev Vaccines; 2006 Oct; 5(5):641-9. PubMed ID: 17181438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Child vaccination, part 1: routine vaccines.
    Zimmerman RK; Burns IT
    J Fam Pract; 2000 Sep; 49(9 Suppl):S22-33. PubMed ID: 11032190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.
    ;
    Expert Rev Vaccines; 2009 Jun; 8(6):705-16. PubMed ID: 19485752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.